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Objective Prior studies examining coronary atherosclerosis in the young have been limited by retrospective analyses in small
cohorts. We examined the relationship between cardiovascular risk factors (RFs) and prevalence and severity of coron-
ary atherosclerosis in a large, prospective, multinational registry of consecutive young individuals undergoing coronary
computerized tomographic angiography (CCTA).
Method
and results
Of 27 125 patients undergoing CCTA, 1635 young (,45 years) individuals without known coronary artery disease
(CAD) or coronary anomalies were identified. Coronary plaque was assessed for any CAD, obstructive CAD (≥50%
stenosis), and presence of calcified plaque (CP) and non-calcified plaque (NCP). Among 1635 subjects (70% men, age
38+ 6 years), any CAD, obstructive CAD, CP, and NCP were observed in 19, 4, 5, and 8%, respectively. Compared
with women, men demonstrated higher rates of any CAD (21 vs. 12%, P, 0.001), CP (6 vs. 3%, P ¼ 0.01), and NCP
(9 vs. 5%, P ¼ 0.008), although no difference was observed for rates of obstructive CAD (5 vs. 4%, P ¼ 0.46). Any
CAD, obstructive CAD, and NCP were higher for young individuals with diabetes, hypertension, dyslipidaemia,
current smoking, or family history of CAD; while only diabetes and dyslipidaemia were associated with CP. Increasing
cardiovascular RFs was associated with a greater prevalence and extent and severity of CAD, with individuals with
0, 1, 2, ≥3 RFs manifesting a dose–response increase in any CAD (P, 0.001, for trend), obstructive CAD
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(P, 0.001, for trend), NCP (P, 0.001, for trend), and CP (P, 0.001, for trend). In multivariable analysis adjusting for
sex and cardiovascular RFs, male sex was the strongest predictor for any CAD (odds ratio [OR] ¼ 1.95, 95% confidence
interval [CI] ¼ 1.43–2.66, P, 0.001), CP (OR ¼ 1.46, 95% CI ¼ 1.08–1.98, P ¼ 0.01), and NCP (OR ¼ 1.33, 95%
CI ¼ 1.06–1.67, P ¼ 0.01); family history of CAD was the strongest predictor for obstructive CAD (OR ¼ 2.71, 95%
CI ¼ 1.65–4.45, P, 0.001).
Conclusion Any and obstructive CAD is present in 1 in 5 and 1 in 20 young individuals, respectively, with family history associated with
the greatest risk of obstructive CAD.
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Introduction
As the prevalence of coronary atherosclerosis has generally been
demonstrated to be low, the determinants and clinical association
of coronary artery disease (CAD) are not well characterized for
young patients.1 – 3 Importantly, prior studies that have investi-
gated the prevalence of coronary atherosclerosis in the young
have been limited to small populations,4 – 11 and the association
between CHD and risk factors (RFs) has been inadequately
examined.
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Table 1 Baseline patient characteristics
Variables All patients, n5 1635 Male, n5 1143 Female, n5 492 P-value
Age, years (mean+ SD) 38+6 38+6 38+6 0.34
BMI, kg/m2a (median, IQR) (27, 24–30) (27, 24–30) (25, 22–31) 0.0001
Diabetes, % 6 5 7 0.31
Dyslipidaemia, % 37 40 30 ,0.001
Hypertension, % 31 31 30 0.65
Current smoking, % 21 23 18 0.05
Family history of CAD, % 33 32 35 0.18
Typical chest pain, % 10 9 11 0.29
Atypical chest pain, % 50 48 56 0.002
Non-cardiac chest pain, % 7 6 9 0.07
Asymptomatic, % 33 37 25 ,0.001
Asymptomatic patients All patients, n ¼ 545 Male, n ¼ 424 Female, n ¼ 121 P-value
Age, years (mean+ SD) 38+6 39+6 38+6 0.14
BMI, kg/m2a (median, IQR) (26, 24–30) (27, 24–30) (25, 22–29) 0.0003
Diabetes, % 6 6 5 0.63
Dyslipidaemia, % 37 40 27 0.009
Hypertension, % 31 32 28 0.46
Current smoking, % 17 18 16 0.57
Family history of CAD, % 31 31 32 0.78
Symptomatic patients All patients, n ¼ 1090 Male, n ¼ 719 Female, n ¼ 371 P-value
Age, years (mean+ SD) 37+6 37+7 38+6 0.02
BMI, kg/m2a (median, IQR) (27, 24–30) (27, 24–30) (26, 23–31) 0.01
Diabetes, % 6 5 7 0.12
Dyslipidaemia, % 37 40 31 0.002
Hypertension, % 31 31 31 0.92
Current smoking, % 23 25 19 0.02
Family history of CAD, % 34 32 36 0.20
Typical chest pain, % 14 14 14 0.94
Atypical chest pain, % 75 76 74 0.58
Non-cardiac chest pain, % 10 10 12 0.38
SD, standard deviation; BMI, body mass index; IQR, inter-quartile range; CAD, coronary artery disease.
aAnalysis of body mass index was performed in 1588 (97%) patients (1107 males and 481 females).
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Coronary computed tomographic angiography (CCTA) is a non-
invasive test that permits direct visualization of CAD with high diag-
nostic performance. In a prospective, multicentre international study
of consecutive individuals undergoing CCTA, we evaluated the
prevalence of coronary atherosclerosis in young subjects and rela-
tionship between coronary atherosclerosis and CAD RFs.
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Table 2 Association of sex and cardiovascular risk factors to coronary atherosclerosis in young patients in CCTA
Overall Malea Femalea P DMa No DMa P
Any CAD 21 12 ,0.001 30 18 0.003
Obstructive CAD 4 4 0.46 9 4 0.03
Presence of NCP 9 5 0.008 14 7 0.02
Presence of CP 6 3 0.01 10 4 0.02
SM No SM P CHOL No CHOL P
Any CAD 23 17 0.01 23 16 0.001
Obstructive CAD 6 4 0.03 7 3 ,0.001
Presence of NCP 10 7 0.04 11 6 0.001
Presence of CP 4 5 0.69 6 4 0.01
FH No FH P HTN No HTN P
Any CAD 23 17 0.002 24 16 ,0.001
Obstructive CAD 7 3 ,0.001 7 3 0.001
Presence of NCP 10 7 0.009 10 7 0.01
Presence of CP 5 4 0.49 5 4 0.44
Asymptomatic patients Malea Femalea P DMa No DMa P
Any CAD 22 15 0.09 34 19 0.04
Obstructive CAD 3 3 1.00 6 3 0.26
Presence of NCP 9 6 0.26 19 8 0.03
Presence of CP 8 3 0.10 19 6 0.007
SM No SM P CHOL No CHOL P
Any CAD 18 21 0.51 24 18 0.10
Obstructive CAD 4 3 0.52 6 1 0.009
Presence of NCP 7 8 0.73 10 7 0.31
Presence of CP 7 7 0.87 9 6 0.19
FH No FH P HTN No HTN P
Any CAD 27 17 0.009 24 19 0.18
Obstructive CAD 6 2 0.002 3 3 1.00
Presence of NCP 12 6 0.02 8 8 0.97
Presence of CP 9 6 0.25 10 6 0.12
Symptomatic patients Malea Femalea P DMa No DMa P
Any CAD 21 11 ,0.001 28 17 0.03
Obstructive CAD 5 4 0.27 10 4 0.05
Presence of NCP 9 5 0.02 12 7 0.21
Presence of CP 4 2 0.14 5 4 0.47
SM No SM P CHOL No CHOL P
Any CAD 25 16 ,0.001 22 15 0.004
Obstructive CAD 7 4 0.046 7 3 0.009
Presence of NCP 11 6 0.007 11 6 0.001
Presence of CP 3 4 0.68 5 3 0.03
FH No FH P HTN No HTN P
Any CAD 21 16 0.047 24 15 ,0.001
Obstructive CAD 8 3 0.002 9 3 ,0.001
Presence of NCP 9 7 0.12 11 6 0.002
Presence of CP 4 4 0.97 3 4 0.68
CCTA, coronary CT angiography; DM, diabetes; CAD, coronary artery disease; CP, calcified plaque; NCP, non-calcified plaque; SM, current smoking; CHOL, dyslipidaemia;
FH, family history of coronary artery disease; HTN, hypertension.
aReported as percentages.
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Methods
Patients
CONFIRM (Coronary CT Angiography Evaluation for Clinical Out-
comes: an International Multicenter Registry) is an international, multi-
centre, observational registry of 27 125 consecutive patients who
underwent ≥64-detector row CCTA clinically referred for suspected
CAD at 12 centres between 2003 and 2009. The study design has been
previously described.12 Each centre obtained approval from their
respective ethics or institutional review board. Of 27 125 consecutive
adult patients at these centres, we excluded 2350 patients with known
CAD (previous myocardial infarction [MI] and/or coronary revasculari-
zation) and 173 patients with coronary anomaly. Among 1635 remaining
patients—defined as 45 years of age or younger—met inclusion criteria
for the current study. The age threshold for inclusion in the study criteria
was chosen in accordance with prior investigations of young patients, as
well as from empirical evidence by CCTA of an exceedingly low preva-
lence of CAD in this population.
Before the scan, physicians or dedicated nurse professionals prospect-
ively collected information on the presence of categorical CAD RFs in
each individual. Systemic arterial hypertension was defined as a docu-
mented history of high blood pressure or treatment with antihyper-
tensive medications. Diabetes mellitus was defined by diagnosis of
diabetes made previously by a physician and/or use of insulin or oral
hypoglycaemic agents. Dyslipidaemia was defined as known but untreat-
ed dyslipidaemia or current treatment with lipid-lowering medications.
A positive smoking history was defined as current smoking or cessation
of smoking within 3months of testing. Positive family history (FH) ofCAD
was determined by patient query and was defined as a MI, sudden cardiac
death, or need for coronary revascularization in a first-degree relative.
Body mass index (BMI) was calculated according to the formula:
weight/height in kg/m2. Chest pain symptom was defined as non-cardiac,
atypical, or typical angina.
Coronary CTA acquisition
CCTAs were performed on a single-source, 64-slice scanner (Light-
speed VCT, GE Healthcare, Milwaukee, WI, USA; SOMATOM Sensa-
tion 64, Siemens Medical Systems, Erlangen, Germany) or dual-source
scanner (Definition or Flash, Siemens Medical Systems). Before imaging,
in patients without contraindications, oral and/or intravenous metopro-
lol was administered in an attempt to achieve a target heart rate ≤65
bpm for single-source scanners or ≤75 bpm for dual-source scanners.
Whenever possible, 0.4 mg sublingual nitroglycerin was administered
3–5 min before image acquisition. Timing bolus or automated bolus
tracking at the proximal ascending aorta was used to determine the time
from contrast injection to optimal coronary artery enhancement. Contrast
(80–140 mL, depending on site) was injected at 5–6 mL/s (rates.6 mL/s
were reserved for very obese patients or patients with very thick chests),
andwhole-volume imageacquisitionwascompleted in a singlebreath-hold.
Acquired image data were initially reconstructed in mid diastole (always)
and end systole (when available). When image quality was suboptimal
on initial reconstruction, multisector reconstruction algorithm with or
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Table 3 Multivariate predictors of any and obstructive CAD on CCTA among young patients
Variables Any CAD Obstructive CAD
OR 95% CI P-value OR 95% CI P-value
Male 2.06 1.50–2.82 ,0.001 1.21 0.69–2.13 0.51
Age 1.11 1.08–1.14 ,0.001 1.07 1.01–1.14 0.02
Diabetes 1.67 1.02–2.73 0.04 1.58 0.70–3.56 0.27
Dyslipidaemia 1.14 0.87–1.49 0.34 1.84 1.10–3.07 0.02
Current smoking 1.37 1.01–1.84 0.04 1.56 0.91–2.67 0.10
Family history of CAD 1.40 1.07–1.83 0.01 2.56 1.56–4.21 ,0.001
Hypertension 1.40 1.07–1.84 0.02 1.82 1.10–3.03 0.02
Asymptomatic patients
Male 1.50 0.85–2.66 0.16 0.75 0.23–2.47 0.64
Age 1.14 1.08–1.21 ,0.001 1.15 0.97–1.36 0.10
Diabetes 2.13 0.93–4.85 0.07 2.66 0.51–13.86 0.25
Dyslipidaemia 0.98 0.62–1.54 0.92 3.16 1.05–9.56 0.04
Current smoking 0.81 0.45–1.47 0.50 1.60 0.48–5.29 0.44
Family history of CAD 1.76 1.12–2.77 0.01 3.70 1.30–10.53 0.01
Hypertension 1.31 0.82–2.11 0.26 0.71 0.23–2.20 0.55
Symptomatic patients
Male 2.26 1.54–3.31 ,0.001 1.50 0.79–2.87 0.22
Age 1.10 1.06–1.14 ,0.001 1.06 1.00–1.13 0.06
Diabetes 1.47 0.79–2.76 0.23 1.44 0.56–3.70 0.45
Dyslipidaemia 1.19 0.86–1.67 0.30 1.54 0.85–2.76 0.15
Current smoking 1.69 1.18–2.41 0.004 1.50 0.82–2.76 0.19
Family history of CAD 1.27 0.91–1.78 0.16 2.31 1.30–4.10 0.004
Hypertension 1.48 1.06–2.08 0.02 2.46 1.37–4.43 0.003
CAD, coronary artery disease; CCTA, coronary CT angiography; OR, odds ratio; CI, confidence interval.
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without manual electrocardiogram (ECG) editing was used to improve
image quality. Reconstructed data were then sent to a workstation,
where a minimum of 1 level III equivalent and/or board-certified reader
in cardiovascular computed tomography employed all necessary post-
processing techniques to determine the presence of CAD in any visible
segment ≥2 mm in diameter, with obstructive CAD defined as a luminal
diameter stenosis .50%. Any CAD was defined as the presence of any
plaque regardless of luminal diameter stenosis.
CCTA interpretation
CCTA interpretation was performed in an intent-to-diagnose fashion for
all CCTAs, in accordance with prior reported investigations. All uninter-
pretable segments were scored with the same stenosis severity as the
most adjacent proximal evaluable segment, in accordance with standard
protocols frompriormulticentre studies.13,14 A16-segmentAHAcoron-
ary artery tree model was used.15 Coronary atherosclerotic lesions were
quantified for lumen diameter stenosis by visual estimation and graded as
none (0% luminal stenosis), mild (1–49%), moderate (50–69%), or
severe (≥70%). Plaque composition in each coronary segment was clas-
sified as calcified, non-calcified, or partially calcified as we have previously
described,16 and the presence of any plaque, calcified, non-calcified, and
partially calcified plaque was also evaluated.
Plaque severity was scored on a per-patient, per-vessel, and per-
segment level. Per-patient maximal plaque severity was defined by
maximal intraluminal stenosis in any of the coronary segments at the
50% stenosis threshold. Any CAD was defined as patients who had any
plaque, irrespective of grade of stenosis.
Statistical analysis
All statistical calculations were performed using STATA (Version 11,
StataCorp LP, College Station, TX, USA) and SAS version 9.2 (SAS Insti-
tute, Cary, NC, USA) for Windows. Categorical variables are presented
as frequencies and continuous variables as mean+ SD. Variables were
compared with Pearson’s x2 test for categorical variables or Fisher’s
exact test where there were cell counts ,6, and by Student’s unpaired
t-test for continuous variables. Comparison of BMIs between genders
was performed with the Kruskal–Wallis non-parametric test. Stepwise
multivariable logistic regression analysis including age, sex, and coronary
RFs was performed to determine the association between these variables
and the presence of obstructive CAD, any CAD, and calcified plaque (CP)
and non-calcified plaque (NCP); these relationships were expressed as
odds ratio (OR) and 95% confidence intervals (CIS). A value of P, 0.05
was considered significant. The x2 test for trend was used to compare
patients with and without obstructive CAD, any CAD and the presence
of CP and NCP across ordered categorical variables.
Results
Clinical characteristics of the study cohort
Characteristics of study population are detailed in Table 1. Among
1635 subjects, 70% was men, 6% had diabetes, 37% had dyslipidae-
mia, 31% had hypertension, 21% had current smoking, and 33%
had FH of CAD. Thirty-three per cent were asymptomatic. The
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Table 4 Multivariate predictors of presence of non-calcified plaque and calcified plaque on CCTA
Variables Non-calcified plaque Calcified plaque
OR 95% CI P-value OR 95% CI P-value
Male 1.83 1.16–2.90 0.01 2.23 1.20–4.13 0.01
Age 1.08 1.04–1.13 ,0.001 1.14 1.07–1.22 ,0.001
Diabetes 1.66 0.87–3.17 0.13 2.15 1.00–4.63 0.05
Dyslipidaemia 1.40 0.96–2.05 0.08 1.36 0.85–2.20 0.20
Current smoking 1.41 0.93–2.13 0.10 0.84 0.47–1.51 0.56
Family history of CAD 1.51 1.04–2.20 0.03 1.10 0.67–1.78 0.71
Hypertension 1.33 0.90–1.97 0.15 0.96 0.58–1.60 0.89
Asymptomatic patients
Male 1.55 0.66–3.62 0.31 2.35 0.80–6.91 0.12
Age 1.05 0.98–1.13 0.16 1.20 1.07–1.35 0.002
Diabetes 3.31 1.19–9.21 0.02 3.31 1.16–9.48 0.03
Dyslipidaemia 1.02 0.53–1.97 0.95 0.96 0.47–1.95 0.90
Current smoking 0.86 0.36–2.01 0.72 1.12 0.46–2.70 0.80
Family history of CAD 2.17 1.15–4.11 0.02 1.53 0.75–3.11 0.24
Hypertension 0.87 0.43–1.75 0.69 1.54 0.75–3.17 0.24
Symptomatic patients
Male 1.93 1.11–3.36 0.02 1.79 0.83–3.86 0.14
Age 1.10 1.04–1.16 0.001 1.11 1.03–1.20 0.007
Diabetes 1.13 0.47–2.70 0.78 1.45 0.41–5.06 0.56
Dyslipidaemia 1.61 1.00–2.58 0.049 1.79 0.92–3.47 0.09
Current smoking 1.70 1.04–2.78 0.03 0.79 0.35–1.76 0.56
Family history of CAD 1.33 0.83–2.12 0.24 0.88 0.45–1.76 0.73
Hypertension 1.61 1.00–2.60 0.049 0.66 0.32–1.38 0.27
CAD, coronary artery disease; CCTA, coronary CT angiography; OR, odds ratio; CI, confidence interval.
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mean age of the overall study group was 38+ 6 years. Men ex-
hibited higher BMI [Median: 27 kg/m2, inter-quartile range (IQR)
[24–30] for males vs. Median: 25 kg/m2, IQR [22–31] for
females (P ¼ 0.0001)] and higher frequency of dyslipidaemia
(male 40% vs. female 30%, P, 0.001). There were no significant
differences in rates of diabetes, hypertension, current smoking,
FH of CAD, and typical chest pain between males and females.
The frequency of asymptomatic status was higher in males than
in females (P, 0.001).
CCTA findings associated with gender
and CAD risk
Among all study subjects, any CAD, obstructive CAD, CP, and NCP
were observed in 19, 4, 5, and 8%, respectively. Compared with
women, men demonstrated higher rates of any CAD (21 vs. 12%,
P, 0.001), NCP (9 vs. 5%, P ¼ 0.008), and CP (6 vs. 3%, P ¼ 0.01),
although no difference was observed for rates of obstructive CAD
(5 vs. 4%, P ¼ 0.46). Any CAD, obstructive CAD, and NCP were
significantly higher for individuals with diabetes, current smoking,
dyslipidaemia, FH of CAD or hypertension; only diabetes and dyslipi-
daemia were significantly associated with CP (Table 2).
Impact of gender or CAD risk factors on
coronary atherosclerosis
In multivariable logistic regression analyses considering age and CAD
risk factors, male gender was the strongest predictor for any CAD
(OR ¼ 1.95, 95% CI ¼ 1.43–2.66, P, 0.001), CP (OR ¼ 1.46,
95% CI ¼ 1.08–1.98, P ¼ 0.01), and NCP (OR ¼ 1.33, 95%
CI ¼ 1.06–1.67, P ¼ 0.01; Tables 3 and 4), while FH of CAD was
the strongest predictor for obstructive CAD (OR ¼ 2.71, 95%
CI ¼ 1.65–4.45, P, 0.001; Table 3).
Impact of number of CAD RFs on
coronary atherosclerosis
Increasing CAD RFs was associated with greater prevalence,
extent, and severity of CAD, with individuals with 0, 1, 2, ≥3
RFs manifesting a dose–response increase in CP (P ¼ 0.008,
for trend), NCP (P, 0.001, for trend), any CAD (P, 0.001,
for trend), and obstructive CAD (P, 0.001, for trend). For
male subjects, increasing number of RFs was also associated
with a greater frequency of CP (P ¼ 0.045, for trend), NCP
(P, 0.001, for trend), any plaque (P, 0.001, for trend), and ob-
structive CAD (P, 0.001, for trend). However, for female
Figure 1 Association between coronary atherosclerosis and number of cardiovascular RFs for (A) the entire study cohort, (B) for male subjects,
and (C) for female subjects. CAD, coronary artery disease; obst CAD, obstructive coronary artery disease, pre CP, presence of calcified plaque;
pre NCP, presence of non-calcified plaque.
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subjects, increasing number of RFs was not significantly asso-
ciated with CP (P ¼ 0.085, for trend), while that was significantly
correlated with NCP (P ¼ 0.001, for trend), any CAD (P ¼
0.014, for trend), and obstructive CAD (P, 0.001, for trend)
(Figure 1). When classified by symptom state, asymptomatic
patients with increasing numbers of RFs possessed increased
CP, NCP, any CAD, and obstructive CAD, a finding that was
evident more for males than for females (Figure 2). For symptom-
atic patients, these trends were observed for NCP, any CAD, and
obstructive CAD but not CP (Figure 3). These relationships were
similar for men and women.
Discussion
In this prospective, multicentre international study of young patients
,45 years of age, we examined prevalence and severity of CAD and
their association to gender and CAD RFs. Further, we examined the
relationship of demographic and CAD RFs to coronary plaque com-
position in a fashion that has not been previously studied. We identi-
fied a common occurrence of CAD by CCTA in young individuals,
with approximately one in five individuals exhibiting any CAD.
Further, despite their young age, there existed a 1 in 20 prevalence
of obstructive CAD in these individuals referred for clinically
indicated CCTA. These prevalences were disproportionate when
comparing gender and CAD RFs, with increasing rates of any ob-
structive CAD in male individuals compared with their female coun-
terpart, as well as for individuals with increasing numbers of
traditional RFs. These observational findings indicate an early patho-
genesis of manifest atherosclerosis that may help inform future inter-
ventions aimed at halting progression of the insidious CAD process.
Prior autopsy-based studies investigating young soldiers who died
from non-cardiac causes have demonstrated that coronary athero-
sclerosis begins early in life. These pathologic studies reported a fre-
quency of coronary atherosclerosis to be 77.3% among Korean
war-era soldiers,5,6,11 while Vietnam war soldiers exhibited identifi-
able coronary atherosclerosis in only 45%, with more severe coron-
ary atherosclerosis observed in 5%.9 Subsequent autopsy studies
reported that the incidence of coronary stenosis increases with age
in studies with subjects ranging from 21 to 39 or 30 to 34 years,4,7
and a higher atherosclerosis presence in men than in women.8
More contemporary analyses employing intravascular ultrasound
(IVUS) on 262 donor heart of a mean age of 33.4+ 13.2 years
within 1 month of cardiac transplantation observed a prevalence of
coronary atherosclerosis that varied from 17% in donor hearts
from individuals ,20 years of age to 85% in donor hearts from
individuals ≥50 years of age.10
Figure 2 Association between coronary atherosclerosis and number of cardiovascular RFs among asymptomatic patients according to (A) the
entire study cohort, (B) for male subjects, and (C) for female subjects.
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The explanation of the variability of CAD prevalence in these
studies is likely multi-fold in nature, but it may certainly be linked to
different study subjects, different methods of CAD examination, dis-
similar definitions of coronary atherosclerosis, and small study popu-
lations. Our present study findings directly extend these prior studies
by prospective evaluation of a significantly larger population that is
international in scope, employing a more systematic and comprehen-
sive evaluation of coronary atherosclerosis by a non-invasive method
with high diagnostic performance. Importantly, among the study
cohort, 70% wereasymptomatic and suggest a hypothesis-generating
notion that these findings may be similar in a population-based study.
The results of this present study should be viewed with caution.
Given the lack of prognostic data associated with the study, no con-
crete conclusion can be drawn regarding the need or timing of early
treatment in young patients for reduction of future adverse cardiovas-
cular events. Future larger studies evaluating the prognostic utility of
any CAD, CP, and NCP will be needed to address this question.
Previous epidemiologic studies have demonstrated a significant as-
sociation between subclinical coronary atherosclerosis and RFs even
in children, adolescents, and young adults.4,8,17,18 Given its magni-
tude, the current study was able to further expand these prior find-
ings by assessing the relationship of sex and CAD risk factors to the
prevalence and severity of coronary atherosclerosis. In this regard,
we identified male gender as the strongest predictor of any coronary
atherosclerosis, as well as for the presence of both CP and NCP in
youngpatients. Wewereable not only to identifywhich demographic
and CAD RFs are associated with higher CAD prevalence, but also
the degree to which these factors predict CAD presence, severity,
and plaque composition. One prior prospective cohort deserved
to be mentioned, having analysed 14 786 middle-aged (age: 25–64
years) men and women in Finland, and investigators found that rela-
tive difference in CHD risk between sexes was largest among 25–49
year old,19 a finding that is in direct accordance with the present
study.2 These observations may be explained, in part, by several
studies that have demonstrated a cardioprotective effect of oestro-
gen through glucose metabolism and haemostatic system;20,21
although an array of other factors deserve equal consideration. In-
terestingly, in this Finnish study, differences in RFs were more favour-
able in women, but sex differences in RF levels diminished with
increasing age.19 These findings suggest a cumulative differential pro-
gression of atherosclerosis due to higher rates of RFs and longer ex-
posure in men than in women. In the present study, FH of CAD was
the strongest predictor for obstructive CAD. This result is concord-
ant with the prior studies that have shown an association between
coronary atherosclerosis and FH of CAD in young patient,22,23 and
the quantification of the direct association of this factor is likely
Figure 3 Association between coronary atherosclerosis and number of cardiovascular RFs among symptomatic patients according to (A) the
entire study cohort, (B) for male subjects, and (C) for female subjects. CAD, coronary artery disease; obst CAD, obstructive coronary artery
disease; pre CP, presence of calcified plaque; pre NCP, presence of non-calcified plaque.
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explained by both genetic and environmental factors.24 Future
studies will be invaluable to further assess this novel observation.
Finally, we have also determined that increasing prevalence of
CAD RFs were significantly associated with the presence of CP,
NCP, any CAD, and obstructive CAD. These results may suggest
that CAD treatment measures in young patients at the time of
atherosclerosis identification may be salutary in nature, and future
studies would be useful to evaluate the therapeutic benefit of treat-
ment of early coronary atherosclerosis.
Study limitations
This study is not without limitations. First, our study findings were
derived from a cohort of individuals who were referred for clinically
indicated CCTA by their physician for suspected CAD, and thus,
extrapolation of our study findings to population-based cohorts
should be done with caution. Secondly, our study findings indicate
the significant associations between the presence and extent of
coronary atherosclerosis self-report which may be subject to ascer-
tainment bias; however, this method is that which is commonly
applied in clinical practice, and thus, the results of our multinational
study may be considered widely generalizable. Third, given the
current limited spatial and temporal resolution of CCTA, it
remains possible that CAD was underestimated compared with
IVUS or autopsy studies. Fourth, the radiation dose conferred
by CCTA is non-negligible, and care must be taken to minimize
exposure in this young population, given the hypothetical risk of
future cancers. Fifth, current generation CCTA is dependent on
single-energy image acquisition and calcium artefacts—including
‘blooming’ from partial volume artefacts are still known to occur.
While the present manuscript employed standard definitions of
CP that have been used consistently in prior investigations, the like-
lihood of small degrees of NCP obscured by CPs cannot be dis-
counted. These findings could also be influenced by the
‘real-world’ design of the study which did not employ a dedicated
core laboratory for image interpretation. Notably, all CCTA
readers were Level III-equivalent physicians with extensive experi-
ence interpreting CCTAs. Further, the pharmacologic therapy of
the study cohort was not known nor were changes in treatment
after the CCTA. Future studies evaluating these findings as it
relates to CAD progression and prognosis are necessary and are
currently being pursued by our laboratory. Sixth, the cross-sectional
nature of the current study limited the long-term assessment of the
conventional RFs and how they might influence the risk of CAD pro-
gression over time. Forthcoming longitudinal studies utilizing time-
updated measures are needed to further our understanding of
how the conventional RFs might impact the progression of CAD.
Finally, the prognostic utility of the findings related to any CAD
and the presence of CP or NCP was not examined in the present
study. Larger observational cohort studies are needed to determine
the ability of these CAD findings by CCTA to further risk stratify
patients beyond traditional CAD risk factors.
Conclusion
Any CADand obstructive CAD are present in 1 in 5 and 1 in 20 young
individuals, respectively, with FH associated with the greatest risk of
obstructive CAD.
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